HSD17B14 Antilichaam - N-terminalgebied: FITC (ARP56864 P050-FITC)

Hydroxysteroid (17-beta) dehydrogenase 14

DHRS10, SDR47C1, retSDR3

51171

Q9BPX1

NP_057330

Human, Mouse, Rat, Dog, Horse, Pig, Rabbit

The immunogen is a synthetic peptide directed towards the N terminal region of human HSD17B14

17-beta-hydroxysteroid dehydrogenases, such as HSD17B14, are primarily involved in metabolism of steroids at the C17 position and also of other substrates, such as fatty acids, prostaglandins, and xenobiotics.

MIR4435-1HG; SREK1IP1; LINC00152; TBC1D22B; WDYHV1; HSD17B14; NEK6; SNRPC; SNAPC3; PHF1; MPG; DDIT3; CDKN2D; CA8; NUDT18; PSMA1

FITC: Fluorescein Isothiocyanate

Polyclonal Antibody

WB

Affinity Purified

0.5 mg/ml

Dog: 100%; Horse: 100%; Human: 100%; Mouse: 92%; Pig: 85%; Rabbit: 92%; Rat: 85%

Liquid. Purified antibody supplied in 1x PBS buffer.

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.

28kDa

Lukacik, P., (2007) Biochem. J. 402 (3), 419-427

Wet Ice

270

HSD17B14

HSD17B14

Rabbit

17-beta-hydroxysteroid dehydrogenase 14

NM_016246

RVVICDKDESGGRALEQELPGAVFILCDVTQEDDVKTLVSETIRRFGRLD